Background
==========

Sepsis is the main cause of death in ICUs all over the world. Early detection of the pathogen is essential for appropriate antimicrobial treatment.

Materials and methods
=====================

To evaluate the reduction in time of antimicrobial adjustment therapy in patients with sepsis comparing a rapid molecular test (SeptiFast^®^) with conventional blood cultures, a randomized controlled clinical trial was conducted between October 2012 and May 2013 in a cardiology hospital. Adult patients staying more than 48 hours in hospital with clinical suspicion of sepsis were included in the study. Blood samples were collected for cultures (BacT/ALERT^®^) and Septifast^®^test immediately prior to initiation of antibiotic therapy. Patients were allocated into two groups. In the Intervention Group (GI), Septifast^®^results were communicated to the medical researcher and antimicrobials were adjusted. In the Control Group (GII), Septifast^®^results were not informed and therapy adjustment was based on the blood culture. Registered in Clinical trials.gov (NCT 01450358).

Results
=======

Forty-six patients were included, 17 in GI and 29 in GII. Key data are shown in Table [1](#T1){ref-type="table"}. In GI therapy adjustment was done in 580 minutes compared with 3,007 minutes in GII (*P*= 0.004).

###### 

Distribution of characteristics in the two groups

                                                            Intervention group (*n*= 17)                                                                                     Control group (*n*= 29)                               *P*value
  --------------------------------------------------------- ---------------------------------------------------------------------------------------------------------------- ----------------------------------------------------- ----------
  Age (years)                                               63 (46 to 75)                                                                                                    66 (39 to 85)                                         0.340
  Gender (female)                                           5 (30%)                                                                                                          10 (34%)                                              0.999
  Hospital stay (mean, days)                                32 (9 to 118)                                                                                                    31 (3 to 112)                                         0.632
  APACHE II (mean)                                          17 (8 to 29)                                                                                                     17 (8 to 29)                                          0.730
  Ejection fraction \<40%                                   8 (47%)                                                                                                          17 (58%)                                              0.545
  Receiving antibiotics prior to study                      11 (65%)                                                                                                         11 (38%)                                              0.126
  Septic shock                                              9 (53%)                                                                                                          16 (55%)                                              0.999
  Patients with adjustment therapy based on SeptiFast^®^    6 (35%)                                                                                                          \-                                                    
  Patients with adjustment therapy based on blood culture   \-                                                                                                               7 (21%)                                               
  Mean time (minutes) of adjustment therapy                 580                                                                                                              3,007                                                 0.004
  Pathogens detected in SeptiFast^®^                        *P. aeruginosa*(2), *K. pneumonia/oxytoca*(1), *E. aerogenes/cloacae*(1), *S. marcescens*(1), *A. baumanii*(1)   \-                                                    
  Pathogens detected in blood culture                       \-                                                                                                               *S. aureus*(4), *K. pneumonia*(2), *M. morganii*(1)   
  28-day mortality                                          9 (53%)                                                                                                          17 (59%)                                              0.765

Conclusions
===========

The rapid molecular test (SeptiFast^®^) reduced the time for adjustment of antibiotic treatment in comparison with conventional blood cultures in critically ill sepsis patients.
